SpringerLink
Log in

Central nervous system metastases in women after multimodality therapy for high risk breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background: Central nervous system (CNS) relapse is increasing in breast cancer. This increase may reflect altered failure patterns from adjuvant therapy, more effective systemic therapy with improved control in non-CNS sites, or a resistant breast cancer subtype.

Methods: To determine the factors associated with clinical CNS relapse, we examined response to neoadjuvant chemotherapy (chemosensitivity), time to relapse and sites of relapse in a cohort of 140 patients without evidence of metastasis at presentation.

Results: At 5 years (interquartile range 3–6 years), 44 (31%) patients developed distant metastases, including 13 with CNS metastases. CNS relapse was early (median 24 months after diagnosis) and associated with relapse in bone and liver, suggesting hematogenous dissemination. Those with CNS relapse were younger at diagnosis (40 versus 49 years) and more likely to have lymphovascular invasion in the primary tumor compared with non-CNS metastases. Response to neoadjuvant chemotherapy was not different (69% versus 73% response rate) between the two groups. Extent of residual disease after chemotherapy was strongly associated with relapse outside the CNS but not CNS relapses. The CNS was an isolated or dominant site of metastasis in 8 of 13. Despite treatment, most patients with CNS involvement died of neurologic causes a median of 6 months later.

Conclusion: Breast cancers that develop CNS metastases differ from those that develop metastases elsewhere. Both tumor behavior and reduced chemotherapy accessibility to the CNS may contribute to increased CNS involvement in breast cancer patients treated with multimodality therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • A DiStefano Y Yong Yap GN Hortobagyi GR Blumenschein (1979) ArticleTitleThe natural history of breast cancer patients with brain metastases Cancer 44 1913–1918

    Google Scholar 

  • AH Paterson M Agarwal A Lees J Hanson O Szafran (1982) ArticleTitleBrain metastases in breast cancer patients receiving adjuvant chemotherapy Cancer 49 IssueID4 651–654

    Google Scholar 

  • JY Pierga B Asselain M Jouve V Dieras M Carton V Laurence V Girre P Beuzeboc T Palangie T Dorval P Pouillart (2001) ArticleTitleEffect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy. Cancer 91 IssueID6 1079–1089

    Google Scholar 

  • JF Stewart RJ King SA Sexton RR Millis RD Rubens JL Hayward (1981) ArticleTitleOestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Euro J Cancer (Oxford) 17 IssueID4 449–453

    Google Scholar 

  • FR Ahmann SE Jones TE Moon (1988) ArticleTitleThe effect of prior adjuvant chemotherapy on survival in metastatic breast cancer J Surg Oncol 37 116–122

    Google Scholar 

  • SE Jones TE Moon (1988) ArticleTitleThe effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Sur Oncol 37 IssueID2 116–122

    Google Scholar 

  • Trudeau ME, Eisenhauer E, Dent S, Pritchard KI, Lofters W, Norris B, Muldal A, Lefendre F, Vandenberg T, Verma S: Central nervous system relapse following chemotherapy with docetaxel for metastatic breast cancer. In: Proceedings of the American Society of Clinical Oncology. 32nd Annual meeting, Philadelphia, PA, May 18–21, 1996, p. 15.

  • D Crivellari O Pagani A Veronesi D Lombardi F Nole B Thurlimann D Hess M Borner J Bauer G Martinelli R Graffeo C Sessa A Goldhirsch (2001) ArticleTitleHigh incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel Ann Oncol 12 353–356

    Google Scholar 

  • Weitzen R, Zach L, Kaufman B, Tichler T, Rath P, Pfeffer R, Baram J, Ben David M, Rizel S, Catane R: High incidence of brain metastasis in patients on trastuzumab for advanced breast cancer. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18–21, 2002, abstract #1936.

  • Wardley AM, Danson S, Clayton AJ, Clemons M, Burt P, Stewart A, Waine S, Wilkinson P, Welch R, Magee B, Howell A: High incidence of brain metastases in patients treated with trastuzumab for metastatic breast cancer at a large cancer center. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18–21, 2002, abstract #241.

  • EE Lower R Blau J Bismayer L Brennan R Broun W Danneman DR Drosick DK Hawley (2001) ArticleTitleIncreased brain metastasis detected in metastatic breast cancer patients. Br Ca Res Treat 69 357a

    Google Scholar 

  • Chock JY, Domchek S, Burstein HJ, Harris L, Younger J, Kuter I, Rue M, Gelman RS, Winer ER: Central nervous system metastases in women who receive trastuzumab for metastatic breast cancer. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18–21, 2002, abstract #218.

  • RJ Freilich AD Seidman LM DeAngelis (1995) ArticleTitleCentral nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 76 IssueID2 232–236

    Google Scholar 

  • C Kosmas NA Malamos NB Tsavaris M Stamataki S Stefanou A Gregoriou S Rokana M Vartholomeou MJ Antonopoulos (2002) ArticleTitleLeptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer. J Neuro-Oncol 56 IssueID3 265–236

    Google Scholar 

  • AD Seidman MN Fornier FJ Esteva L Tan S Kaptain A Bach KS Panageas C Arroyo V Valero V Currie T Gilewski (2001) ArticleTitleWeekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol 19 IssueID10 2587–2595

    Google Scholar 

  • ES Singletary C Allred P Ashley LW Bassett D Berry KI Bland PI Burgen G Clark SB Edge DF Hayes LL Hughes RVP Hutter M Morrow DL Page A Recht RL Theriault A Hor DL Weaver HS Wieand FL Greene (2002) ArticleTitleRevision of the American Joint Committee on Cancer Staging System for Breast Cancer J Clin Oncol 20 3628–3636

    Google Scholar 

  • Cance WG Carey LA Calvo BF Sartor C Sawyer L Moore DT Rosenman J Ollila DW M Graham 2nd (2002) ArticleTitleLong-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236 IssueID3 295–302

    Google Scholar 

  • N Wolmark J Wang E Mamounas J Bryant B Fisher (2001) ArticleTitlePreoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Ca Inst Monographs 30 96–102

    Google Scholar 

  • HM Kuerer AA Sahin KK Hunt LA Newman TM Breslin FC Ames MI Ross AU Buzdar GN Hortobagyi SE Singletary (1999) ArticleTitleIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 IssueID1 72–78

    Google Scholar 

  • W Boogerd VW Vos AA Hart G Baris (1993) ArticleTitleBrain metastases in breast cancer; natural history, prognostic factors and outcome. J Neuro-Oncol 15 IssueID2 165–174

    Google Scholar 

  • C Kamby B Ejlertsen J Andersen NE Birkler L Rytter K Zedeler C Rose (1988) ArticleTitleThe pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival Acta Oncol 27 IssueID6A 715–719

    Google Scholar 

  • Y Tsukada A Fouad JW Pickren WW Lane (1983) ArticleTitleCentral nervous system metastasis from breast carcinoma: Autopsy study Cancer 52 IssueID12 2349–2354

    Google Scholar 

  • S Zimm GL Wampler D Stablein T Hazra HF Young (1981) ArticleTitleIntracerebral metastases in solid-tumor patients: natural history and results of treatment Cancer 48 IssueID2 384–394

    Google Scholar 

  • SM Monte Particlede la GM Hutchins GW Moore (1988) ArticleTitleInfluence of age on the metastatic behavior of breast carcinoma Human Pathology 19 IssueID5 529–534

    Google Scholar 

  • FB Hagemeister AU Buzdar MA Luna GR Blumenschein (1980) ArticleTitleCauses of death in breast cancer: a clinicopathologic study Cancer 46 IssueID1 162–167

    Google Scholar 

  • KD Miller T Weathers LG Haney R Timmerman M Dickler J Shen GW Sledge (2001) ArticleTitleOccult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival Br Ca Res Treat 69 214a

    Google Scholar 

  • GJ Lesser SA Grossman S Eller EK Rowinsky (1995) ArticleTitleThe distribution of systemically administered [3H]-paclitaxel in rats: a quantitative autoradiographic study Cancer Chemotherapy Pharmacol 37 IssueID1-2 173–178

    Google Scholar 

  • BC Pestalozzi S Brignoli (2000) ArticleTitleTrastuzumab in CSF J Clinl Oncol 18 IssueID11 2349–2351

    Google Scholar 

  • JC Bendell SM Domchek HJ Burstein L Harris J Younger I Kuter C Bunnell M Rue R Gelman E Winer (2003) ArticleTitleCentral nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97 IssueID12 2972–2977

    Google Scholar 

  • E Viadana R Cotter JW Pickren IDJ Bross (1973) ArticleTitleAn autopsy study of metastatic sites of breast cancer Cancer Res 33 179–181

    Google Scholar 

  • LJ Schouten J Rutten HA Huveneers A Twijnstra (2002) ArticleTitleIncidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94 IssueID10 2698–2705

    Google Scholar 

  • GM Clark GW Sledge CK Osborne WL McGuire (1987) ArticleTitleSurvival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 5 IssueID1 55–61

    Google Scholar 

  • DD Maki RI Grossman (2000) ArticleTitlePatterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status. Am J Neuroradiol 21 IssueID6 1064–1066

    Google Scholar 

  • Lai RK, Dang C, Thaler H, Malkin MG: The incidence of brain metastases in HER2/neu+ stage IV breast cancer patients. In: Proceedings of the American Society of Clinical Oncology. 37th Annual meeting, San Fransisco, CA, May 12–15, 2001, abstract #2014

  • GA Rosenberg (2002) ArticleTitleMatrix metalloproteinases in neuroinflammation. GLIA 39 IssueID3 279–291

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, CB7305, University of North Carolina, 3009 Old Clinic Building, Chapel Hill, NC, 27599-7305, USA

    Lisa A. Carey, E. Claire Dees & Mark L. Graham

  2. Division of Neurosurgery, Department of Surgery, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

    Matthew G. Ewend

  3. Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

    Richard Metzger, Lynda Sawyer & Dominic T. Moore

  4. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Carolyn I. Sartor

Authors
  1. Lisa A. Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew G. Ewend
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Metzger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lynda Sawyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Claire Dees
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carolyn I. Sartor
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dominic T. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mark L. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa A. Carey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, L.A., Ewend, M.G., Metzger, R. et al. Central nervous system metastases in women after multimodality therapy for high risk breast cancer. Breast Cancer Res Treat 88, 273–280 (2004). https://doi.org/10.1007/s10549-004-0999-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-004-0999-3

Keywords

Search

Navigation